OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
32
Results
Show all
Save search
Copy query
Show results for
Unknown
(32)
Publication Date
Release Date
2022
(6)
2021
(6)
2015
(4)
2025
(3)
2023
(3)
2011
(3)
2024
(2)
2016
(2)
2014
(2)
2012
(1)
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
HLA-B∗46 associates with rapid HIV disease progression in Asian cohorts and prominent differences in NK cell phenotype.
Not available
S-EPMC9380401
|
biostudies-literature
Cite
Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis: The BLING III Randomized Clinical Trial.
Not available
S-EPMC11170452
|
biostudies-literature
Cite
Ataluren treatment of patients with nonsense mutation dystrophinopathy.
Not available
S-EPMC4241581
|
biostudies-literature
Cite
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial.
Not available
S-EPMC3111069
|
biostudies-literature
Cite
Using CD4 percentage and age to optimize pediatric antiretroviral therapy initiation.
Not available
S-EPMC4179097
|
biostudies-literature
Cite
HIV-1 Drug Resistance and Second-Line Treatment in Children Randomized to Switch at Low Versus Higher RNA Thresholds.
Not available
S-EPMC4556171
|
biostudies-literature
Cite
Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.
Not available
S-EPMC10334296
|
biostudies-literature
Cite
Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).
Not available
S-EPMC4588097
|
biostudies-literature
Cite
Fatal and Nonfatal Events Within 14 days After Early, Intensive Mobilization Poststroke.
Not available
S-EPMC8055346
|
biostudies-literature
Cite
Exploring threats to generalisability in a large international rehabilitation trial (AVERT).
Not available
S-EPMC4550737
|
biostudies-literature
Cite
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets